Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- Harmony Outcomes committees and investigators
Research output: Contribution to journal › Article › peer-review
1584
Link opens in a new tab
Scopus
citations